NCT07027384 (KSI-RCT) is a NA clinical trial of Web-Based Apps PRIMA in Primary Health Care for Children, sponsored by Center for Indonesia's Strategic Development Initiatives.

Who is sponsoring NCT07027384?

NCT07027384 is sponsored by Center for Indonesia's Strategic Development Initiatives.

What drugs are being tested in NCT07027384?

Interventions in NCT07027384: Web-Based Apps PRIMA, Apps PRIMA Mobile, Advance GEDSI Training.

What condition does NCT07027384 study?

NCT07027384 studies Primary Health Care for Children, Nutritional Status.

Is NCT07027384 still recruiting?

NCT07027384 is currently active, enrolled. Last updated 23 February 2026.

Last reviewed 2026-02-23 · How we verify

NCT07027384: KSI-RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Digital Decision-support Tool for Child Nutritional Monitoring: a Protocol for Cluster Randomized Controlled Trial in Urban and Semi-Urban Areas in Indonesia

Active, enrolled NA Last updated 23 February 2026

What this trial tests

NA trial testing Web-Based Apps PRIMA in Primary Health Care for Children in 1,030 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

8 July 2025

Primary endpoint
31 May 2026

1 July 2026

Quick facts

Lead sponsor	Center for Indonesia's Strategic Development Initiatives
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	1,030
Start date	8 July 2025
Primary completion	31 May 2026
Estimated completion	1 July 2026
Sites	6 locations across Indonesia

Drugs / interventions tested

Web-Based Apps PRIMA
Apps PRIMA Mobile
Advance GEDSI Training

Conditions studied

Primary Health Care for Children — all drugs for Primary Health Care for Children →
Nutritional Status — all drugs for Nutritional Status →

Sponsor

Center for Indonesia's Strategic Development Initiatives

Who can join

Eligibility, any sex, with Primary Health Care for Children or Nutritional Status. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is a collaborative study between Indonesia's Strategic Development Initiatives (CISDI), Knowledge Partnership Platform Australia - Indonesia (KONEKSI), Center on Child Protection and Wellbeing (PUSKAPA), and Center for Development Economics and Sustainability at Monash University. This study is a part of the PN PRIMA research universe, which is a program lead by CISDI with a focus of strengthening the primary healthcare facilities of Indonesia, known as Integrated Health Posts (Posyandu). This project supports the Ministry of Health's (MoH) flagship program: the Integrated Primary Health Care Services (ILP). This study aims to evaluate the impact of implementing a digital mHealth app, called the PN PRIMA app, in enhancing the work quality of Community Health Workers working in Posyandu, known as Kader. This study specifically improve the PN PRIMA app from a web-based platform to a mobile application. We aim to improve data quality, streamline service delivery workflows, and enhance decision-making support for community health workers. The enhanced version incorporates new features and Gender Equality, Disability, and Social Inclusion (GEDSI) framework to strengthen primary health care delivery. Impact evaluation of the study will be conducted through a three-arm parallel cluster randomized controlled trial. Posyandu will be the unit in which randomization will occur. The primary outcomes focuses on the improvements of Kader Posyandu performance in delivering follow-up home visits and how the app effectively support Kader in delivering nutrition interventions for children under five years of age. The study will be conducted in the Puskesmas PN PRIMA catchment area, located in Kabupaten Bekasi and Kota Depok, focusing the intervention at the Posyandu level. In total, 38 Posyandu out of 12 health centers (Puskesmas) across the two areas will be recruited to take part in this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07027384 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Center for Indonesia's Strategic Development Initiatives
Last refreshed: 23 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07027384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing